• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

AJMC in the Press, August 26, 2016

Article

A review of our peer-reviewed research, in the healthcare and mainstream press.

Studies from the current issue of The American Journal of Managed Care have been cited frequently this week.

New research from the CVS Health Research Institute was one of the most-cited articles this week. The study found that interventions to keep patients with common chronic conditions on their medication are very cost effective, especially if those interventions target patients who take 3 or more medications. Payers can save between $38 million and $63 million per 100,000 members by focusing on these patient populations. Multiple outlets cited the study, including The Pharmacist, the official publication of the American Pharmacist Association.

In addition, the Center for Infectious Disease Research and Policy at the University of Minnesota discussed an article by CDC authors, who found that more than three-fourths of adults diagnosed as having bronchitis receive an antibiotic, even though antibiotics are not indicated for this condition.

Related Videos
Sudipto Mukherjee, MD, PhD, MPH, hematology and medical oncology, Cleveland Clinic
Video 12 - "Key Considerations for Treating Patients Diagnosed With CLL and SLL"
Video 11 - "Optimizing BTKi Treatment Strategies"
Video 13 - "Other Clinical Considerations in Demodex Blepharitis Treatment"
James Robinson, PhD, MPH, University of California, Berkeley
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.